|
Bio-Path Holdings Announces the Relocation of Corporate Headquarters to ...
MarketWatch (press release) Bio-Path's drug delivery technology involves microscopic-sized liposome particles that distribute nucleic acid drugs systemically and safely throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to ... |
Read the full story:
Bio-Path Holdings Announces the Relocation of Corporate Headquarters to ... - MarketWatch (press release)
You must log in to post a comment.